Crispr Therapeutics Ag (CRSP)
$51.42 -5.23% Close Oct 30, 2026 Live
Crispr Therapeutics Ag stock today
Crispr Therapeutics Ag closed at $51.42 on October 30, 2026, down 5.23% on the day. Over the past year it returned -15.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.96 billion.
$50.00$60.00
NovJan 2026MarMayJulSep
| Period | CRSP | S&P 500 (SPY) |
|---|---|---|
| 1 month | -7.0% | -0.9% |
| 3 months | +6.2% | +2.1% |
| Year to date | -1.9% | +11.7% |
| 1 year | -15.8% | +12.4% |
| 3 years | +32.1% | +88.5% |
| 5 years | -43.7% | +76.0% |
Key statistics
- Market value
- $4.96B
- Price / sales
- 370.3
- 52-week range
- $44.34 to $63.99
- Next report
- Nov 9, 2026 (estimated)
About Crispr Therapeutics Ag
Develops gene-editing therapies using CRISPR technology to treat genetic diseases.
Sector: Health Care
More on Crispr Therapeutics Ag
- Financials: revenue, earnings and segmentsRevenue -91% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $3,072 today
No forecast, no recommendation. This page describes Crispr Therapeutics Ag from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.